Physicians have access to a variety of testing options to determine the best treatment to fit each patient. From medical management to the most advanced devices and surgical options are available to patients at Cleveland Clinic.
Diagnostic Capabilities: The Kaufman Center for Heart Failure offers a full range of diagnostic capabilities for heart failure.
Medical Management of Heart Failure: The Kaufman Center for Heart Failure physicians medically manage heart failure patients with the newest, state-of-the-art medications to slow the disease's progression, keep patients out of the hospital, and reduce mortality. Our nurses and cardiac rehabilitation team counsels patients on diet, exercise and lifestyle change to optimize the patient’s ability to participate in activities of daily living and limit symptoms.
Electrical Device Management of Heart Failure: Heart and Vascular Institute electrophysiologists provide cardiac resynchronization therapy (CRT) with biventricular pacemakers and prevent life-threatening heart beats with implantable cardioverter defibrillators (ICD). These devices can improve heart function, quality of life and decrease mortality (death) in appropriate patients with advanced heart failure. Learn more about:
Surgical Management of Heart Failure: Surgical management involves a wide range of procedures from high risk conventional surgeries to transplant and mechanical circulatory support.
High Risk Conventional Surgery: Cleveland Clinic cardiovascular surgeons are experienced in treating the highest risk patients. Surgeries include:
Learn more about surgery for heart failure. Advances in minimally invasive, robotically assisted, thorascopic and percutaneous approaches gives heart surgeons many options in caring for the high risk cardiac surgery patient.
Heart Transplant Program: Cleveland Clinic’s Cardiac Transplant Program is a key component of the Kaufman Center for Heart Failure. Cleveland Clinic performed 52 heart transplants in 2010, of which 5 were heart/lung transplants; and has performed 1521 transplants since the start of the program. The program continues to achieve excellent outcomes. The Scientific Registry of Transplant Recipients (SRTR) demonstrates that for patients receiving their first transplant between July 1, 2007 and December 31, 2009, 92 percent of adult recipients were alive one year after transplant, compared with the expected 88 percent (based on the characteristics of recipients and donors, as well as on the experience of similar patients throughout the United States). For patients receiving their first transplant between January 1, 2005 and June 30, 2007, the three year survival rate for our program was 84 percent compared with the 81 percent that was expected, based on national experience. These excellent results are testimony to the outstanding multidisciplinary care of our transplant program. Learn more about Cleveland Clinic's Heart Transplant Program.
Mechanical Circulatory Support (MCS) Devices: With over 20 years experience, the Kaufman Center for Heart Failure has significant depth and breadth of experience with mechanical circulatory support, utilizing pumps for acute support, as a bridge to transplant, and permanent support for patients not candidates for organ replacement. In 2010, we implanted 52 devices. Access to and expertise with mechanical support devices (Thoratec’s Heartmate II®, Syncardia’s Total Artificial Heart®, and HeartWare®) allow us to utilize the optimal device for each individual patient. Learn more about ventricular assist devices.
An 8-year-old male was only the third patient in Ohio to receive the EXCOR Pediatric implant. Manufactured by Berlin Heart, this device supported his diseased heart until he was transplanted with a donor heart in December 2010.
Women and Heart Failure: Despite the fact that women account for nearly 50% of all hospital admissions for heart failure, only 25% of women are involved in heart failure studies. The Center for Women and Heart Failure was developed in 2005 to improve the care of women with heart failure via education, treatment, and research. Our goal is to focus more attention on women in heart failure research so that we can eventually tailor therapy to meet individual heart failure treatment needs.
Heart Failure Disease Management Program: Initiated in 1999, the Heart Failure Management Program allows doctors and nurses to provide frequent contact with patients (through office visits, telephone calls or home monitoring) to alleviate symptoms, prevent symptoms from recurring and decrease the need for emergency care or hospitalization. In this program, emphasis is placed on increasing patient's knowledge of heart failure and helping to self-manage this condition.
Heart Care at Home: This program blends innovative telehealth monitoring technology with traditional home healthcare services to support patients following hospitalization for heart failure. Through the combined resources of Cleveland Clinic Homecare Services and the Heart and Vascular Institute, Heart Care at Home is one possible technological solution to providing cost-effective patient contact for a growing population of patients with chronic heart failure. This program has the potential to both monitor and promote self-care in an efficient, effective manner. Learn more about Heart Care at Home.